resistanceBio is a California-based biopharma company dedicated to finding cures for drug-resistant cancers.

Our mission is to defeat treatment-resistant cancer.

Using our proprietary drug and target discovery platform, the ResCu system, we harness evolution to identify novel targets to fight drug-resistant cancers and provide hope for patients for whom existing therapies have failed. We’ve developed a novel class of multi-targeted oncology treatments, Resistance Suppressing Therapy (ReST).